Syneos Health Stock Forecast, Price & News

Syneos Health (NASDAQ:SYNH) Frequently Asked Questions

Is Syneos Health a buy right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Syneos Health in the last twelve months. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Syneos Health stock.
View analyst ratings for Syneos Health or view top-rated stocks.

How has Syneos Health's stock been impacted by COVID-19?

Syneos Health's stock was trading at $57.30 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, SYNH shares have increased by 52.5% and is now trading at $87.36.
View which stocks have been most impacted by COVID-19.

When is Syneos Health's next earnings date?

Syneos Health is scheduled to release its next quarterly earnings announcement on Thursday, February 17th 2022.
View our earnings forecast for Syneos Health.

How were Syneos Health's earnings last quarter?

Syneos Health, Inc. (NASDAQ:SYNH) issued its quarterly earnings data on Wednesday, November, 3rd. The company reported $1.22 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $1.17 by $0.05. The firm had revenue of $1.35 billion for the quarter, compared to analysts' expectations of $1.34 billion. Syneos Health had a trailing twelve-month return on equity of 11.71% and a net margin of 5.04%. The business's revenue was up 22.7% compared to the same quarter last year. During the same quarter last year, the company earned $0.93 EPS.
View Syneos Health's earnings history.

What guidance has Syneos Health issued on next quarter's earnings?

Syneos Health issued an update on its FY 2021 earnings guidance on Wednesday, November, 10th. The company provided EPS guidance of $4.350-$4.490 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.350. The company issued revenue guidance of $5.20 billion-$5.28 billion, compared to the consensus revenue estimate of $5.25 billion.

What price target have analysts set for SYNH?

6 Wall Street analysts have issued 12-month target prices for Syneos Health's shares. Their forecasts range from $90.00 to $122.00. On average, they expect Syneos Health's stock price to reach $106.17 in the next twelve months. This suggests a possible upside of 21.5% from the stock's current price.
View analysts' price targets for Syneos Health or view top-rated stocks among Wall Street analysts.

Who are Syneos Health's key executives?

Syneos Health's management team includes the following people:

• Alistair John Macdonald, Chief Executive Officer & Director (LinkedIn Profile)
• Jason Michael Meggs, Chief Financial Officer & Executive Vice President
• Larry A Pickett, Chief Information & Digital Officer
• Michelle Keefe, President-Commercial Solutions
• Paul D. Colvin, Chief Business Officer

What is Alistair Macdonald's approval rating as Syneos Health's CEO?

322 employees have rated Syneos Health CEO Alistair Macdonald on Glassdoor.com. Alistair Macdonald has an approval rating of 82% among Syneos Health's employees.

Who are some of Syneos Health's key competitors?

Some companies that are related to Syneos Health include Bitcoin Group (BTGGF), Charles River Laboratories International (CRL), Incyte (INCY), ICON Public (ICLR), Exact Sciences (EXAS), Medpace (MEDP), SomaLogic (SLGC), Science 37 (SNCE), Anavex Life Sciences (AVXL), National Research (NRC), Absci (ABSI), Zymergen (ZY), Inotiv (NOTV), Starpharma (SPHRY) and Luna Innovations (LUNA).
View all of SYNH's competitors.

What other stocks do shareholders of Syneos Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Syneos Health investors own include NVIDIA (NVDA), Pfizer (PFE), Square (SQ), Advanced Micro Devices (AMD), Boeing (BA), Alibaba Group (BABA), ICON Public (ICLR), Netflix (NFLX), AbbVie (ABBV) and Intel (INTC).

What is Syneos Health's stock symbol?

Syneos Health trades on the NASDAQ under the ticker symbol "SYNH."

Who are Syneos Health's major shareholders?

Syneos Health's stock is owned by a number of retail and institutional investors. Top institutional investors include Vaughan Nelson Investment Management L.P. (0.76%), Retirement Systems of Alabama (0.13%), AMI Asset Management Corp (0.07%), Louisiana State Employees Retirement System (0.03%), First Hawaiian Bank (0.02%) and State of Alaska Department of Revenue (0.01%). Company insiders that own Syneos Health stock include Alistair Macdonald, Donna Hildebrand Kralowetz, International Corp/Ma Advent, Jason M Meggs, John L Maldonado, John M Dineen, Jonathan Olefson, Linda S Harty, Mark E Jagiela, Matthew E Monaghan, Michael Lee Brooks, Michelle Keefe, Paul Colvin, Robert Parks, Thomas H Lee Advisors, Llc and Tom Allen.
View institutional ownership trends for Syneos Health.

Which institutional investors are selling Syneos Health stock?

SYNH stock was sold by a variety of institutional investors in the last quarter, including Vaughan Nelson Investment Management L.P., AMI Asset Management Corp, Crossmark Global Holdings Inc., and State of Alaska Department of Revenue. Company insiders that have sold Syneos Health company stock in the last year include Alistair Macdonald, Donna Hildebrand Kralowetz, International Corp/Ma Advent, Jason M Meggs, John L Maldonado, Jonathan Olefson, Linda S Harty, Mark E Jagiela, Matthew E Monaghan, Michael Lee Brooks, Michelle Keefe, Thomas H Lee Advisors, Llc, and Tom Allen.
View insider buying and selling activity for Syneos Health or view top insider-selling stocks.

Which institutional investors are buying Syneos Health stock?

SYNH stock was purchased by a variety of institutional investors in the last quarter, including First Hawaiian Bank, Sheets Smith Wealth Management, Courier Capital LLC, Retirement Systems of Alabama, AE Wealth Management LLC, Louisiana State Employees Retirement System, and Fulton Bank N.A.. Company insiders that have bought Syneos Health stock in the last two years include Jason M Meggs, John M Dineen, and Paul Colvin.
View insider buying and selling activity for Syneos Health or or view top insider-buying stocks.

How do I buy shares of Syneos Health?

Shares of SYNH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Syneos Health's stock price today?

One share of SYNH stock can currently be purchased for approximately $87.36.

How much money does Syneos Health make?

Syneos Health has a market capitalization of $9.06 billion and generates $4.42 billion in revenue each year. The company earns $192.79 million in net income (profit) each year or $2.39 on an earnings per share basis.

How many employees does Syneos Health have?

Syneos Health employs 25,000 workers across the globe.

What is Syneos Health's official website?

The official website for Syneos Health is www.syneoshealth.com.

Where are Syneos Health's headquarters?

Syneos Health is headquartered at 1030 Sync Street, Morrisville NC, 27560.

How can I contact Syneos Health?

Syneos Health's mailing address is 1030 Sync Street, Morrisville NC, 27560. The company can be reached via phone at (919) 876-9300, via email at [email protected], or via fax at 919-876-9360.